Stilla Technologies expands U.S. presence through strategic distribution relationship with Avantor and introduces advanced content offerings

FHS
June 20, 2024
9:06 am

Stilla, a pioneer in the field of genomics and digital PCR, is excited to announce its expansion in the United States via a strategic distribution relationship with Avantor, a global leader in life sciences and advanced technology solutions.

Acelyrin announces layoffs, strategy shift after late-stage trial results for anti-inflammatory drug

Acelyrin, a California biotech focused on immunology and inflammatory disease, announced Tuesday that its experimental drug for a common skin disorder succeeded in a late-stage

August 13, 2024

Plus Therapeutics, PPS expand partnership for drug production

The injectable radiotherapy rhenium (186Re) obisbemeda has the potential to minimise risks and enhance outcomes for CNS cancer patients. Credit: fernando zhiminaicela from Pixabay. Plus

May 2, 2023

FDA approves study of Versameb’s mRNA therapy in urinary incontinence – Pharmaceutical Technology

Share this article The Phase IIa study of the mRNA treatment is scheduled to start in the first half of 2024. Credit: valiantsin suprunovich via

November 16, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.